| Financial Year |
March 31 2023 |
| Monetary Funds |
342,337,895.22 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,392,596.13 |
| Accounts Receivable |
899,280,636.76 |
| Advances to Suppliers |
9,806,530.90 |
| Other Receivables |
41,786,608.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
893,037,072.77 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,828,212.41 |
| Other Current Assets |
10,851,614.84 |
| Total Current Assets |
2,366,442,171.16 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
11,819,662.74 |
| Long-term Equity Investment |
259,438,919.31 |
| Investment Properties |
28,488,073.83 |
| Fixed Assetes |
2,472,023,292.74 |
| Under-construction Projects |
180,785,938.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
370,659,295.44 |
| R&D expenses |
-- |
| Goodwill |
575,870,583.05 |
| Long-Term Deferred and Prepaid Expenses |
84,140,760.09 |
| Deferred Income Tax Assets |
75,554,244.26 |
| Other Non-Current Assets |
9,855,082.54 |
| Sub-Total of Non-Current Assets |
4,141,740,968.91 |
| Total Assets |
6,508,183,140.07 |
| Short-Term Loans |
592,877,999.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
111,294,336.71 |
| Accounts Payable |
352,165,604.72 |
| Accounts Received In Advance |
174,617.98 |
| Employee Compensation Payable |
31,803,948.58 |
| Taxes Payable |
24,269,428.58 |
| Interest Payable |
-- |
| Dividend Payable |
2,000,000.00 |
| Other payables |
155,860,054.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
226,499,276.13 |
| Other Current Liabilities |
381,577.48 |
| Sub-Total of Current Liabilities |
1,499,714,168.25 |
| Long-term Loans |
1,920,630,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
35,104,936.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,127,415,400.77 |
| Total Liabilities |
3,627,129,569.02 |
| Paid-In Capital(Or Share Stock) |
616,383,477.00 |
| Capital Surplus |
1,022,691,664.95 |
| Surplus Reserve |
199,414,675.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
688,706,202.25 |
| Minority Stockholder's Interest |
348,351,412.44 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,532,702,158.61 |
| Owner's Equity（Stockholder's Equity） |
2,881,053,571.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,508,183,140.07 |
